Obesity as a Risk Factor for Autoimmune Diseases: A Systematic Review and Meta‐Analysis
Obesity · 2026-01 · 34 (1) · 36-50
DOI: 10.1002/oby.70044 ↗At a glance
Systematische Übersicht in Obesity, published online on 2025-11-04. Written by Ilaria Spatocco and 12 co-authors. Institution: Dipartimento di Medicina Molecolare e Biotecnologie Mediche, Università Degli Studi di Napoli Federico II, Napoli, Italy. Major MEDLINE topics: Obesity, Autoimmune Diseases. Cited 12 times so far (Crossref); 66 references. The full text is freely available (open access, CC BY 4.0). Funded by: Fondazione Italiana Sclerosi Multipla, Juvenile Diabetes Research Foundation, Mechanism Leading to Loss of Immune-Tolerance.
Abstract (original language)
Objective
Obesity is characterized by a proinflammatory condition contributing to poor outcomes, but its association with autoimmunity is inconclusive. To fill this gap in knowledge, we searched PubMed and Embase for studies analyzing the association between obesity and the prevalence and/or incidence of autoimmune diseases.
Methods
Adjusted odds ratios (OR) or hazard ratios (HR) with 95% CI relating to the prevalence or incidence of autoimmune diseases in people with BMI > 30, compared to BMI < 25, were pooled using generic inverse variance and fixed effect models. Of 1,311 records, 26 (8 cross‐sectional and 18 longitudinal) studies were included in the meta‐analysis.
Results
Obesity, compared with normal weight, was associated with increased prevalence of rheumatoid arthritis and psoriasis (OR = 1.11 [1.06, 1.16], p < 0.00001; OR = 1.35 [1.14, 1.59], p = 0.0004, respectively) and increased risk of developing rheumatoid arthritis (HR = 1.30 [1.15, 1.49], p < 0.0001), psoriasis (HR = 1.18 [1.16, 1.20], p < 0.00001), multiple sclerosis (HR = 1.49 [1.25, 1.77], p < 0.00001), and Crohn's/ulcerative colitis (HR = 1.35 [1.11, 1.65], p < 0.003). Obesity was also significantly associated with incidence of any autoimmune disease (HR = 1.41 [1.24, 1.62], p < 0.00001).
Conclusions
Although definitive conclusions are still precluded for the single diseases, overall evidence supports obesity as a risk factor for autoimmunity. image
Subjects
MeSH terms (MEDLINE)
Author keywords
Authors and institutions
- Dipartimento di Medicina Molecolare e Biotecnologie Mediche, Università Degli Studi di Napoli Federico II, Napoli, Italy.
- Laboratorio di Immunologia, Istituto Degli Endotipi in Oncologia, Metabolismo e Immunologia 'G. Salvatore', Consiglio Nazionale Delle Ricerche (IEOMI-CNR), Napoli, Italy.
- Azienda Ospedaliera Universitaria 'Federico II', Napoli, Italy.
- IRCCS MultiMedica, Milano, Italy.
- Unità di Neuroimmunologia, Fondazione Santa Lucia, Roma, Italy.
ORCID profiles: Giusy De Rosa, Francesco Prattichizzo
Funding
- Fondazione Italiana Sclerosi Multipla
- Juvenile Diabetes Research Foundation
- Mechanism Leading to Loss of Immune-Tolerance
- Italian Ministry of Health
- Ministry of Health
- JDRF
Cite
APA
Spatocco, I., Mele, G., De Rosa, G., Fusco, C., Ruggiero, K., Pellegrini, V., Carreras, F., La Grotta, R., Ceriello, A., Procaccini, C., Matarese, G., Prattichizzo, F., & de Candia, P. (2026). Obesity as a Risk Factor for Autoimmune Diseases: A Systematic Review and Meta‐Analysis. Obesity, 34(1), 36-50. https://doi.org/10.1002/oby.70044
Vancouver
Spatocco I, Mele G, De Rosa G, Fusco C, Ruggiero K, Pellegrini V, et al. Obesity as a Risk Factor for Autoimmune Diseases: A Systematic Review and Meta‐Analysis. Obesity. 2026;34(1):36-50. doi:10.1002/oby.70044
BibTeX
@article{Spatocco2026,
author = {Spatocco, Ilaria and Mele, Giorgia and De Rosa, Giusy and Fusco, Clorinda and Ruggiero, Kristyna and Pellegrini, Valeria and Carreras, Francesca and La Grotta, Rosalba and Ceriello, Antonio and Procaccini, Claudio and Matarese, Giuseppe and Prattichizzo, Francesco and de Candia, Paola},
title = {Obesity as a Risk Factor for Autoimmune Diseases: A Systematic Review and Meta‐Analysis},
journal = {Obesity},
year = {2026},
volume = {34},
number = {1},
pages = {36--50},
doi = {10.1002/oby.70044}
}
EUVIMED